Book contents
- Frontmatter
- Contents
- PREFACE
- CONTRIBUTORS
- PART ONE ANATOMY AND THE AGING PROCESS
- PART TWO ANESTHESIA AND SEDATION FOR OFFICE COSMETIC PROCEDURES
- PART THREE FILLERS AND NEUROTOXINS
- Chap. 6 FILLERS: PAST, PRESENT, AND FUTURE
- Chap. 7 HYALURONIC ACID FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 8 RESTYLANE: GENERAL CONCEPTS
- Chap. 9 THE RESTYLANE FAMILY OF FILLERS: CANADIAN EXPERIENCE
- Chap. 10 THE JUVÉDERM FAMILY OF FILLERS
- Chap. 11 PURAGEN: A NEW DERMAL FILLER
- Chap. 12 PURAGEN: ASIAN EXPERIENCE
- Chap. 13 REVIEW OF COLLAGEN FILLERS
- Chap. 14 HUMAN AND BOVINE COLLAGEN-BASED FILLERS
- Chap. 15 PORCINE COLLAGEN: EVOLENCE
- Chap. 16 CALCIUM HYDROXYLAPATITE (RADIESSE): A FACIAL PLASTIC SURGEON'S APPROACH
- Chap. 17 CALCIUM HYDROXYLAPATITE (RADIESSE): A DERMASURGEON'S APPROACH
- Chap. 18 CALCIUM HYDROXYLAPATITE FOR HAND VOLUME RESTORATION
- Chap. 19 LONG-LASTING FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 20 ACRYLIC PARTICLE–BASED FILLERS: ARTEFILL
- Chap. 21 POLY-L-LACTIC ACID FILLERS
- Chap. 22 POLY-L-LACTIC ACID (SCULPTRA) FOR HAND VOLUME RESTORATION
- Chap. 23 BIOALKAMIDE
- Chap. 24 SILICONE
- Chap. 25 AUTOLOGOUS FAT TRANSFER: AN INTRODUCTION
- Chap. 26 SMALL-VOLUME FAT TRANSFER
- Chap. 27 LARGER-VOLUME FAT TRANSFER
- Chap. 28 FAMI TECHNIQUE AND FAT TRANSFER FOR HAND REJUVENATION
- Chap. 29 ADDING VOLUME TO THE AGING FACE: FAT GRAFTING VERSUS FILLERS AND IMPLANTS IN EUROPE
- Chap. 30 FILLERS: HOW WE DO IT
- Chap. 31 CHOOSING A FILLER
- Chap. 32 FILLER COMPLICATIONS
- Chap. 33 NEUROTOXINS: PAST, PRESENT, AND FUTURE
- Chap. 34 BOTOX: HOW WE DO IT
- Chap. 35 COSMETIC BOTOX: HOW WE DO IT
- Chap. 36 BOTOX: BEYOND THE BASICS
- Chap. 37 BOTOX FOR HYPERHIDROSIS
- Chap. 38 DYSPORT
- Chap. 39 NEUROTOXIN ALTERNATIVE: RADIOFREQUENCY CORRUGATOR DENERVATION
- Chap. 40 FILLERS AND NEUROTOXINS IN ASIA
- Chap. 41 FILLERS AND NEUROTOXINS IN SOUTH AMERICA
- PART FOUR COSMETIC APPLICATIONS OF LIGHT, RADIOFREQUENCY, AND ULTRASOUND ENERGY
- PART FIVE OTHER PROCEDURES
- INDEX
- References
Chap. 16 - CALCIUM HYDROXYLAPATITE (RADIESSE): A FACIAL PLASTIC SURGEON'S APPROACH
from PART THREE - FILLERS AND NEUROTOXINS
Published online by Cambridge University Press: 06 July 2010
- Frontmatter
- Contents
- PREFACE
- CONTRIBUTORS
- PART ONE ANATOMY AND THE AGING PROCESS
- PART TWO ANESTHESIA AND SEDATION FOR OFFICE COSMETIC PROCEDURES
- PART THREE FILLERS AND NEUROTOXINS
- Chap. 6 FILLERS: PAST, PRESENT, AND FUTURE
- Chap. 7 HYALURONIC ACID FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 8 RESTYLANE: GENERAL CONCEPTS
- Chap. 9 THE RESTYLANE FAMILY OF FILLERS: CANADIAN EXPERIENCE
- Chap. 10 THE JUVÉDERM FAMILY OF FILLERS
- Chap. 11 PURAGEN: A NEW DERMAL FILLER
- Chap. 12 PURAGEN: ASIAN EXPERIENCE
- Chap. 13 REVIEW OF COLLAGEN FILLERS
- Chap. 14 HUMAN AND BOVINE COLLAGEN-BASED FILLERS
- Chap. 15 PORCINE COLLAGEN: EVOLENCE
- Chap. 16 CALCIUM HYDROXYLAPATITE (RADIESSE): A FACIAL PLASTIC SURGEON'S APPROACH
- Chap. 17 CALCIUM HYDROXYLAPATITE (RADIESSE): A DERMASURGEON'S APPROACH
- Chap. 18 CALCIUM HYDROXYLAPATITE FOR HAND VOLUME RESTORATION
- Chap. 19 LONG-LASTING FILLERS: HOW STRUCTURE AFFECTS FUNCTION
- Chap. 20 ACRYLIC PARTICLE–BASED FILLERS: ARTEFILL
- Chap. 21 POLY-L-LACTIC ACID FILLERS
- Chap. 22 POLY-L-LACTIC ACID (SCULPTRA) FOR HAND VOLUME RESTORATION
- Chap. 23 BIOALKAMIDE
- Chap. 24 SILICONE
- Chap. 25 AUTOLOGOUS FAT TRANSFER: AN INTRODUCTION
- Chap. 26 SMALL-VOLUME FAT TRANSFER
- Chap. 27 LARGER-VOLUME FAT TRANSFER
- Chap. 28 FAMI TECHNIQUE AND FAT TRANSFER FOR HAND REJUVENATION
- Chap. 29 ADDING VOLUME TO THE AGING FACE: FAT GRAFTING VERSUS FILLERS AND IMPLANTS IN EUROPE
- Chap. 30 FILLERS: HOW WE DO IT
- Chap. 31 CHOOSING A FILLER
- Chap. 32 FILLER COMPLICATIONS
- Chap. 33 NEUROTOXINS: PAST, PRESENT, AND FUTURE
- Chap. 34 BOTOX: HOW WE DO IT
- Chap. 35 COSMETIC BOTOX: HOW WE DO IT
- Chap. 36 BOTOX: BEYOND THE BASICS
- Chap. 37 BOTOX FOR HYPERHIDROSIS
- Chap. 38 DYSPORT
- Chap. 39 NEUROTOXIN ALTERNATIVE: RADIOFREQUENCY CORRUGATOR DENERVATION
- Chap. 40 FILLERS AND NEUROTOXINS IN ASIA
- Chap. 41 FILLERS AND NEUROTOXINS IN SOUTH AMERICA
- PART FOUR COSMETIC APPLICATIONS OF LIGHT, RADIOFREQUENCY, AND ULTRASOUND ENERGY
- PART FIVE OTHER PROCEDURES
- INDEX
- References
Summary
With their safety, effectiveness, and longevity increasing, public interest in soft tissue fillers is proportionally increasing. Patients not yet ready for traditional cosmetic surgery are looking for simpler means to correct the gravitational and deleterious effects of aging. Be it the atrophy of facial fat, the thinning of lips, the furrowing of the middle and lower face, or the deepening of the melolabial (nasolabial) folds, soft tissue fillers offer an immediate and relatively uncomplicated corrective measure. Calcium hydroxylapatite (Radiesse, Bioform Inc.) is a recent entry into the cosmetic surgery practitioner's armamentarium.
CaHA is a biocompatible material that has the important qualities of being latex-free, nontoxic, nonmutagenic, nonantigenic, and nonirritating. It is a semisolid, cohesive implant material consisting of CaHA microspheres that range from 25 to 45 μm in diameter, suspended in a gel consisting of water, glycerin, and carboxymethylcellulose. CaHA is an inorganic component normally found in teeth and bone, thus its attractive safety profile. CaHA, which should be injected in a subdermal plane, has been shown to elicit no foreign body reaction or toxicity.
Although it has been used safely, and with Food and Drug Administration (FDA) approval, in laryngeal augmentation; soft tissue marking; and oral, maxillofacial, and dental defects for many years, it was not until January 2007, after extensive off-label use and study, that it was FDA approved for cosmetic facial soft tissue augmentation.
As with all procedures, the patient should be counseled regarding the risks of CaHA injection, specifically bleeding, ecchymoses, and edema.
- Type
- Chapter
- Information
- Office-Based Cosmetic Procedures and Techniques , pp. 71 - 73Publisher: Cambridge University PressPrint publication year: 2010